Dr. Deepak Kumar Khajuria

Dr. Deepak Kumar Khajuria

Research Scientist
Al-Ameen College of Pharmacy, India


Highest Degree
Ph.D. in Pharmacology from Rajiv Gandhi University of Health Sciences, India

Share this Profile

Biography

Mr. Deepak Kumar Khajuria starts his professional career in 2010 as Research Scholar, Al-Ameen College of Pharmacy, Bangalore, India. Mr. Deepak Kumar Khajuria received his B. Pharm. in Pharmacy in 2006 at St. Johns College of Pharmacy, Bangalore, India. Mr. Deepak Kumar Khajuria received his M. Pharm. in Pharmacology in 2009 at Krupanidhi College of Pharmacy, Bangalore, India. Mr. Deepak Kumar Khajuria currently is a Ph.D. Student at Al-Ameen College of Pharmacy, Bangalore, India.

Mr. Deepak Kumar Khajuria Currently working on a Preclinical Research Project, "To develop Novel Formulations for the Treatment and Prevention of Osteoporosis in Rat Models". The research work is in collaboration with Laboratory for Integrative Multiscale Engineering Materials and Systems, Department of Aerospace Engineering, Indian Institute of Sciences, Bangalore.

Mr. Deepak Kumar Khajurias current research interests are Immunopharmacology, Neuropharmacology, Endocrine Pharmacology, Nanotechnology, Targeted Drug Delivery.

Area of Interest:

Pharmacology and Toxicology
100%
Pharmaceutical Sciences
62%
Pharmacy
90%
Drug Delivery
75%
Immunopharmacology
55%

Selected Publications

  1. Kolanthai, E., D.K. Khajuria, S.C. Veerla, D. Kuppuswamy, L.H. Catalani and D.R. Mahapatra, 2018. Graphene oxide-a tool for preparation of chemically crosslinking free alginate-chitosan-collagen scaffold for bone tissue engineering. ACS Applied Mater. Interfaces, 10: 12441-12452.
    CrossRef  |  Direct Link  |  

  2. Khajuria, D.K., M. Raygorodskaya, E. Kobyliansky, Y. Gabet and S.H. Bab et al., 2018. Evaluation of the long-term skeletal effect induced by teratogen 5-aza-2′ deoxycytidine on offspring of high (C3H/HeJ) and low (C57BL/6J) bone mass phenotype mice. Bone Rep., 8: 239-243.
    CrossRef  |  PubMed  |  Direct Link  |  

  3. Khajuria, D.K., Kumar, D. Gigi, A. Gedanken and D. Karasik, 2018. Accelerated bone regeneration by nitrogen-doped carbon dots functionalized with hydroxyapatite nanoparticles. ACS Applied Mater. Interfaces, 10: 19373-19385.
    CrossRef  |  PubMed  |  Direct Link  |  

  4. Khajuria, D.K., V.B. Kumar, D. Karasik and A. Gedanken, 2017. Fluorescent nanoparticles with tissue-dependent affinity for live zebrafish imaging. ACS Appl. Mater. Interfaces, 9: 18557-18565.
    CrossRef  |  Direct Link  |  

  5. Khajuria, D.K., S.F. Zahra and R. Razdan, 2017. Effect of locally administered novel biodegradable chitosan based risedronate/zinc-hydroxyapatite intra-pocket dental film on alveolar bone density in rat model of periodontitis. J. Biomater. Sci. Polym. Ed., 10.1080/09205063.2017.1400145.
    CrossRef  |  PubMed  |  Direct Link  |  

  6. Khajuria, D.K., R. Vasireddi, M. Trebbin, D. Karasik and R. Razdan, 2017. Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: In vitro and pharmacodynamic evaluation. Mater. Sci. Eng. C, 71: 698-708.
    CrossRef  |  Direct Link  |  

  7. Khajuria, D.K., O.N. Patil, D. Karasik and R. Razdan, 2017. Development and evaluation of novel biodegradable chitosan based metformin intrapocket dental film for the management of periodontitis and alveolar bone loss in a rat model. Arch. Oral Biol., 85: 120-129.
    CrossRef  |  PubMed  |  Direct Link  |  

  8. Khajuria, D.K., C. Disha, R. Vasireddi, R. Razdan and D.R. Mahapatra, 2016. Risedronate/zinc-hydroxyapatite based nanomedicine for osteoporosis. Mater. Sci. Eng. C, 63: 78-87.
    CrossRef  |  Direct Link  |  

  9. Khajuria, D.K., R. Razdan and D.R. Mahapatra, 2015. Effect of combined treatment with zoledronic acid and propranolol on mechanical strength in an rat model of disuse osteoporosis. Rev. Bras. Reumatologia, 55: 501-511.
    CrossRef  |  PubMed  |  Direct Link  |  

  10. Khajuria, D.K., R. Razdan and D.R. Mahapatra, 2015. Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model. Eur. J. Pharm. Sci., 66: 173-183.
    CrossRef  |  Direct Link  |  

  11. Khajuria, D.K., R. Razdan and D.R. Mahapatra, 2015. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats. Rev. Bras. Reumatologia, 55: 103-112.
    CrossRef  |  PubMed  |  Direct Link  |  

  12. Khajuria, D.K., C. Disha, R. Razdan and D.R. Mahapatra, 2015. Additive effect of zoledronic acid and alfacalcidol in the treatment of disuse osteoporosis in rats. Rev. Bras. Reumatologia, 55: 240-250.
    CrossRef  |  PubMed  |  Direct Link  |  

  13. Weh, F.H., M. Razavi, C.H. Erh, M.I. Noordin and S. Nyamathulla et al., 2014. Formulation and In Vitro evaluation of hydrodynamically balanced matrix tablets of famotidine using pectin as controlled release polymer. Lat. Am. J. Pharm., 33: 420-431.
    Direct Link  |  

  14. Khajuria, D.K., R. Razdan and D.R. Mahapatra, 2014. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats. J. Orthopaedic Sci., 19: 646-656.
    CrossRef  |  PubMed  |  Direct Link  |  

  15. Khajuria, D.K., C.Disha, R. Razdan, D.R. Mahapatra and R. Vasireddi, 2014. Prophylactic effects of propranolol versus the standard therapy on a new model of disuse osteoporosis in rats. Sci. Pharm., 82: 357-374.
    CrossRef  |  Direct Link  |  

  16. Sahana, H., D.K. Khajuria, R. Razdan, D.R. Mahapatra and M.R. Bhat et al., 2013. Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis. J. Biomed. Nanotechnol., 9: 193-201.
    CrossRef  |  PubMed  |  Direct Link  |  

  17. Khajuria, D.K., S. Joseph, R. Razdan, D.R. Mahapatra and M. Kachroo et al., 2013. Novel eudragit coated alloxan nanoparticle based formulation for inducing type 2 diabetes mellitus in rats. J. Nanopharm. Drug Delivery, 1: 394-403.
    CrossRef  |  Direct Link  |  

  18. Khajuria, D.K., R. Razdan, D.R. Mahapatra and M.R. Bhat, 2013. Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol. J. Orthopaedic Sci., 18: 832-842.
    CrossRef  |  Direct Link  |  

  19. Khajuria, D.K., C. Disha, R. Razdan, D.R. Mahapatra and M.R. Bhat, 2013. Comparative evaluation of zoledronic acid, alfacalcidol, and propranolol in pharmacological correction of experimental osteoporosis. Latin Am. J. Pharm., 32: 968-976.
    Direct Link  |  

  20. Razavi, M., N.K. Meera, H. Karimian and D.K. Khajuria, 2012. A Profile of Drug Utilization Among Elderly Inpatients Admitted at a Tertiary Level Hospital in Bangalore: A Prospective Study. Arch. Pharm. Pract., 3: 217-222.
    Direct Link  |  

  21. Rao, G.S., M. Razavi, H. Karimian, N.P. Kumar and D.K. Khajuria et al., 2012. Antinociceptive Effect of Terminalia bellirica in Diabetic Peripheral Neuropathy: a Comparison with Fluoxetin, Imipramine and Quercetin. Lat. Am. J. Pharm., 31: 520-525.
    Direct Link  |  

  22. Moinuddin, G., K. Devi and D.K. Khajuria, 2012. Evaluation of the Anti-Depressant Activity of Myristica fragrans (Nutmeg) in Male Rats. Avicenna J. Phytomed., 2: 72-78.
    Direct Link  |  

  23. Khajuria, D.K., R. Razdan and D.R. Mahapatra, 2012. Description of a new method of ovariectomy in female rats. Rev. Bras. Reumatol., 52: 462-470.
    PubMed  |  Direct Link  |  

  24. Moinuddin, G., K. Devi, H. Satish and D.K. Khajuria, 2011. Comparative pharmacological evaluation of Hypericum perforatum and Rosmarinus officinalis for anti-depressant activity. Lat. Am. J. Pharm., 30: 1028-1032.
    Direct Link  |  

  25. Khajuria, D.K., R. Razdan and D.R. Mahapatra, 2011. Drugs for the management of osteoporosis: A review. Rev. Bras Reumatol., 51: 365-382.
    Direct Link  |  

  26. Pradeep, S., N. Prem Kumar, D.K. Khajuria and G. Srinivas Rao, 2010. Preclinical evaluation of antinociceptive effect of Withania somnifera (Ashwagandha) in Diabetic Peripheral Neuropathic rat models. Pharmacologyonline, 2: 283-298.
    Direct Link  |  

  27. Moinuddin, G., K.S. Devi, H. Satish, D.K. Khajuria, 2010. Comparative pharmacological evaluation of Ocium santum and imipramine for antidepressant activity. Lat. Am. J. Pharm., 30: 435-439.
    Direct Link  |  

  28. Khajuria, D.K., M. Asad, S.M.B. Asdaq and P. Kumar, 2010. The Potency of Crocus sativus (Saffron) and its constituent crocin as an immunomodulator in animals. Lat. Am. J. Pharm., 29: 713-718.
    Direct Link  |  

  29. Kumar, P.S.R., S.M. Asdaq, N. Prem Kumar, M. Asad and D.K. Khajuria, 2009. Protective effect of Zizyphus jujuba fruit extract against Paracetamol and Thioacetamide induced Hepatic damage in rats. The Internet J. Pharmacol., Vol. 7, No. 1. .
    Direct Link  |